Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Discovery & Development Advanced Medicine

Automating Cell Therapy Manufacturing

| James Strachan

Is autologous cell therapy a realistic proposition for solid tumors?

Discovery & Development Trends & Forecasts

Fueling Precision Medicine

| Darlene Solomon

In the 20th century, physics and chemistry reshaped the world. Here’s why biology will be the game-changer in the 21st century.

Manufacture Technology and Equipment

Now You See It

| Andrea Sardella

What are the challenges and best practices in quality control for difficult-to-inspect products?

Manufacture Drug Discovery

Bringing Certainty to CAR T-Cell Discovery

| Jim Ross

How can we maximize the potential and production of potentially life-saving therapies?

Manufacture Bioprocessing - Upstream & Downstream

A Matter of Expression

| Joachim Klein, Julian Riba

Lonza and Cytena combine expertise to allow biotherapeutic manufacturers to benefit from the advantages of Pichia pastoris as an expression system.

Manufacture Advanced Medicine

Video Interview: Talking Cell Therapy Trends

Edd Stone of TTP explains how the industry is overcoming the manufacturing challenges associated with cell therapies.

Manufacture Bioprocessing - Upstream & Downstream

Continuous Progress

| Doug Hausner

What role can regulators play in overcoming the barriers to the adoption of continuous manufacturing processes?

Manufacture Bioprocessing - Upstream & Downstream

Boosting Cell Line Expression

Why is there a need for innovation in cell line development technology?

Manufacture Analytical Science

Nominations for the 2021 Innovation Awards

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

Manufacture Bioprocessing - Single Use Systems

Continuous: Before you Leap, Consider this

| Niklas Jungnelius

Is there data demonstrating significant cost benefits from continuous biomanufacturing?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register